Advertisement
UK markets close in 2 hours 2 minutes
  • FTSE 100

    8,117.74
    +38.88 (+0.48%)
     
  • FTSE 250

    19,788.45
    +186.47 (+0.95%)
     
  • AIM

    755.11
    +1.99 (+0.26%)
     
  • GBP/EUR

    1.1672
    +0.0016 (+0.13%)
     
  • GBP/USD

    1.2505
    -0.0006 (-0.05%)
     
  • Bitcoin GBP

    51,052.23
    +528.93 (+1.05%)
     
  • CMC Crypto 200

    1,382.14
    -14.40 (-1.03%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    84.13
    +0.56 (+0.67%)
     
  • GOLD FUTURES

    2,360.00
    +17.50 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,071.78
    +154.50 (+0.86%)
     
  • CAC 40

    8,056.00
    +39.35 (+0.49%)
     

Science in Sport (LON:SIS) Share Prices Have Dropped 63% In The Last Three Years

Investing in stocks inevitably means buying into some companies that perform poorly. But the last three years have been particularly tough on longer term Science in Sport plc (LON:SIS) shareholders. Unfortunately, they have held through a 63% decline in the share price in that time. And more recent buyers are having a tough time too, with a drop of 46% in the last year. Unhappily, the share price slid 1.5% in the last week.

Check out our latest analysis for Science in Sport

Science in Sport wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. When a company doesn't make profits, we'd generally expect to see good revenue growth. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

ADVERTISEMENT

In the last three years, Science in Sport saw its revenue grow by 50% per year, compound. That's well above most other pre-profit companies. In contrast, the share price is down 18% compound, over three years - disappointing by most standards. This could mean hype has come out of the stock because the losses are concerning investors. When we see revenue growth, paired with a falling share price, we can't help wonder if there is an opportunity for those who are willing to dig deeper.

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

earnings-and-revenue-growth
earnings-and-revenue-growth

This free interactive report on Science in Sport's balance sheet strength is a great place to start, if you want to investigate the stock further.

A Different Perspective

We regret to report that Science in Sport shareholders are down 46% for the year. Unfortunately, that's worse than the broader market decline of 14%. However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 8.6% over the last half decade. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Take risks, for example - Science in Sport has 3 warning signs (and 1 which shouldn't be ignored) we think you should know about.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on GB exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.